Literature DB >> 11157321

Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men.

I Marques-Lopes1, D Ansorena, I Astiasaran, L Forga, J A Martínez.   

Abstract

BACKGROUND: Adjustments of carbohydrate intake and oxidation occur in both normal-weight and overweight individuals. Nevertheless, the contribution of carbohydrates to the accumulation of fat through either reduction of fat oxidation or stimulation of fat synthesis in obesity remains poorly investigated.
OBJECTIVE: The objective of this study was to assess the postprandial metabolic changes and the fractional hepatic de novo lipogenesis (DNL) induced by a high-carbohydrate, low-fat meal in lean and overweight young men.
DESIGN: A high-carbohydrate, low-fat meal was administered to 6 lean and 7 overweight men after a 17.5-h fast. During the fasting and postprandial periods, energy expenditure (EE), macronutrient oxidation, diet-induced thermogenesis, and serum insulin, glucose, triacylglycerol, and fatty acids were measured. To determine DNL, [1-13C]sodium acetate was infused and the mass isotopomer distribution analysis method was applied.
RESULTS: After intake of the high-carbohydrate meal, the overweight men had hyperinsulinemia and higher fatty acid and triacylglycerol concentrations than did the lean men. The overweight group showed a greater EE, whereas there was no significant difference in carbohydrate oxidation between the groups. Nevertheless, the overweight men had a marginally higher protein oxidation and a lower lipid oxidation than did the lean men. DNL was significantly higher before and after meal intake in the overweight men and was positively associated with fasting serum glucose and insulin concentrations. Furthermore, postprandial DNL was positively correlated with body fat mass, EE, and triacylglycerol.
CONCLUSION: After a high-carbohydrate, low-fat meal, overweight men had a lower fat oxidation and a higher fractional hepatic fat synthesis than did lean men.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157321     DOI: 10.1093/ajcn/73.2.253

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  54 in total

Review 1.  Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Authors:  Jun Kusunoki; Akio Kanatani; David E Moller
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Metabolomics identifies changes in fatty acid and amino acid profiles in serum of overweight older adults following a weight loss intervention.

Authors:  A Perez-Cornago; L Brennan; I Ibero-Baraibar; H H M Hermsdorff; A O'Gorman; M A Zulet; J Alfredo Martínez
Journal:  J Physiol Biochem       Date:  2014-01-09       Impact factor: 4.158

3.  Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  N L Weir; B T Steffen; W Guan; L M Johnson; L Djousse; K J Mukamal; M Y Tsai
Journal:  Diabetes Metab       Date:  2019-11-06       Impact factor: 6.041

4.  Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity.

Authors:  Rebecca J Ford; Morgan D Fullerton; Stephen L Pinkosky; Emily A Day; John W Scott; Jonathan S Oakhill; Adam L Bujak; Brennan K Smith; Justin D Crane; Regje M Blümer; Katarina Marcinko; Bruce E Kemp; Hertzel C Gerstein; Gregory R Steinberg
Journal:  Biochem J       Date:  2015-05-15       Impact factor: 3.857

5.  Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study.

Authors:  Dariush Mozaffarian; Haiming Cao; Irena B King; Rozenn N Lemaitre; Xiaoling Song; David S Siscovick; Gökhan S Hotamisligil
Journal:  Ann Intern Med       Date:  2010-12-21       Impact factor: 25.391

6.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

7.  Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.

Authors:  Joseph J Lee; Jennifer E Lambert; Yelena Hovhannisyan; Maria A Ramos-Roman; Justin R Trombold; David A Wagner; Elizabeth J Parks
Journal:  Am J Clin Nutr       Date:  2014-11-19       Impact factor: 7.045

Review 8.  Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.

Authors:  Samir Softic; David E Cohen; C Ronald Kahn
Journal:  Dig Dis Sci       Date:  2016-02-08       Impact factor: 3.199

Review 9.  Recent findings in the study of postprandial lipemia.

Authors:  E J Parks
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

10.  Hyperphagia modifies FA profiles of plasma phospholipids, plasma FFA, and adipose tissue TAG.

Authors:  Gudrun V Skuladottir; Pall I Olason; Logi Jonsson; Jon O Skarphedinsson; Vedis H Eriksdottir; Palmi Th Atlason; Leifur Franzson; Helgi B Schiöth
Journal:  Lipids       Date:  2003-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.